These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2055814)

  • 21. Susceptibility of clinical isolates of Bacteroides fragilis group strains to cefoxitin, cefoperazone and ticarcillin/clavulanate.
    Peixoto Júnior AA; Rocha MM; Moreira JL; Carvalho CB
    Rev Inst Med Trop Sao Paulo; 2000; 42(3):137-9. PubMed ID: 10887372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-lactamases from Bacteroides fragilis active against oximino-cephalosporins.
    Werner RG; Appel KR; Erne AM
    Arzneimittelforschung; 1985; 35(1A):348-50. PubMed ID: 3872669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection of beta-lactamases in the Bacteroides fragilis group].
    Martin C; Dubreuil L; Sedallian A; Romond C
    Pathol Biol (Paris); 1990 May; 38(5):470-3. PubMed ID: 2367153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of ceftizoxime against Bacteroides fragilis: comparison with benzylpenicillin, cephalothin, and cefoxitin.
    Eley A; Greenwood D
    Antimicrob Agents Chemother; 1981 Sep; 20(3):332-5. PubMed ID: 6272629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newer beta-lactam agents and the Bacteroides fragilis group.
    Cuchural GJ
    Pharmacotherapy; 1991; 11(2 ( Pt 2)):51S-55S. PubMed ID: 2041832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and characterization of an imipenem hydrolysing metallo-beta-lactamase from Bacteroides fragilis.
    Hedberg M; Edlund C; Lindqvist L; Rylander M; Nord CE
    J Antimicrob Chemother; 1992 Feb; 29(2):105-13. PubMed ID: 1506324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial effect of beta-lactam antibiotic combinations against Bacteroides fragilis in vitro.
    Bansal MB; Thadepalli H
    Antimicrob Agents Chemother; 1983 Jan; 23(1):166-8. PubMed ID: 6830206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. beta-lactamases in bacteroides.
    Nord CE; Olsson B; Dornbusch K
    Scand J Infect Dis Suppl; 1978; (13):27-32. PubMed ID: 28561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical importance of cefoxitin-resistant Bacteroides fragilis isolates.
    Bieluch VM; Cuchural GJ; Snydman DR; Gorbach SL; Tally FP
    Diagn Microbiol Infect Dis; 1987 Jun; 7(2):119-26. PubMed ID: 3652652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
    Brook I
    J Infect Dis; 1989 Oct; 160(4):651-6. PubMed ID: 2677161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989.
    Cuchural GJ; Snydman DR; McDermott L; Iannini PB; Hill GB; Cleary TJ; O'Keefe JP; Pierson CL; Rihs JD; Finegold SM
    Clin Ther; 1992; 14(1):122-36. PubMed ID: 1576621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations to the penicillin-binding proteins in the Bacteroides fragilis group: a mechanism for non-beta-lactamase mediated cefoxitin resistance.
    Wexler HM; Halebian S
    J Antimicrob Chemother; 1990 Jul; 26(1):7-20. PubMed ID: 2211448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem.
    Eley A; Greenwood D
    J Med Microbiol; 1986 Feb; 21(1):49-57. PubMed ID: 3485198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefoxitin resistance in Bacteroides species: evidence indicating two mechanisms causing decreased susceptibility.
    Piddock LJ; Wise R
    J Antimicrob Chemother; 1987 Feb; 19(2):161-70. PubMed ID: 3571041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic activity of cefsulodin combined with cefoxitin and sulbactam against Bacteroides species.
    Fu KP; Kimble EF; Zoganas H; Konopka EA
    J Antimicrob Chemother; 1984 Mar; 13(3):257-65. PubMed ID: 6327598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of two beta-lactam antibiotics against strains of the Bacteroides fragilis group isolated from humans and from Callithrix penicillata marmosets.
    Avila-Campos MJ; de Carvalho MA; Veiga-Damasceno CA; Osório-Cisalpino E
    Rev Latinoam Microbiol; 1994; 36(3):159-62. PubMed ID: 7709091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Augmentation effect of clavulanic acid with penicillin, cephalothin and ticarcillin against Bacteroides fragilis.
    Bansal MB; Chuah SK; Oryema-Lalobo M; Thadepalli H
    Chemotherapy; 1985; 31(3):173-7. PubMed ID: 3996086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)].
    Tytgat F
    Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of cefotetan and Sch 34343 to beta-lactamases produced by strains of Bacteroides that hydrolyse cefoxitin or imipenem.
    Andrew JH; Greenwood D
    J Antimicrob Chemother; 1987 May; 19(5):591-5. PubMed ID: 3497146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro antibacterial activity of cefotetan against Bacteroides fragilis group clinical isolates.
    Menozzi M; Avanzini P; Lecchini R; Bigi M; Chezzi C
    Chemioterapia; 1987 Jun; 6(2 Suppl):88-91. PubMed ID: 3509541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.